IMMUNO-ONCOLOGY
- Target development
- Bispecifics
- CAR-T cell therapies
- Engineered B cells delivering genes
- AAV based therapies
- Development of NHP immunology models
- Immunogenicity and toxicity assessment in NHPs
- T cell activation biomarkers in monkeys
- Cell and gene therapy